INSIGHTS ON DRUG DEVELOPMENT

• Efficient mAb Development With A Flexible Purification Toolkit

  Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.

• Easy Automation For Cell-Based Assays

  Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.

• Neoantigen-Based Personalized Cancer Vaccine

  Personalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.

• Improving Gene Therapy Development With Organ-On-A-Chip Technology

  Explore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.

• mRNA Manufacturing With Fed-Batch In Vitro Transcription

  2/13/2026

  A milliliter-scale approach to IVT optimization reveals how controlled feeding, precise pH management, and real-time monitoring can boost mRNA yield and streamline scale-up to larger bioreactor volumes.

• Quicker Development Using Cell Line Integration, End-To-End Support

  6/19/2025

  Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.

• Sustainability In On-Body Delivery System Platforms

  7/2/2026

  Explore how our on-body delivery system supports high-volume biologic delivery by balancing usability, patient needs, and sustainability through research-driven design.

• API Solubility And Dissolution Enhancement Via Formulation

  6/4/2025

  Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.

• Navigating Nitrosamine Impurities In Pharmaceutical Drug Development

  3/3/2026

  Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.